By bridging preclinical evidence with clinical perspectives, this article seeks to highlight the translational potential of HMGB1 in improving AKI diagnosis, treatment, and prognosis, ultimately advancing the management of this life-threatening condition. Here, HMGB1 is linked to acute kidney injury.